x

Hungary

FamiCord services are provided by Krio Intézet

Italy

FamiCord services are provided by Sorgente

Germany

FamiCord services are provided by eticur)

Latvia

FamiCord services are provided by Climes Sunu Banka

Luxemburg

FamiCord services are provided by Stemlab

Poland

FamiCord services are provided by Polski Bank Komórek Macierzystych

Portugal

FamiCord services are provided by Crioestaminal

Romania

FamiCord services are provided by Biogenis

Spain

FamiCord services are provided by Sevibe

Switzerland

FamiCord services are provided by Stemlab

Turkey

FamiCord services are provided by Yaşam Bankası

Albania

FamiCord services are provided by Biosave

Bosnia & Herzegovina

FamiCord services are provided by Biosave

Croatia

FamiCord services are provided by Biosave

Denmark

FamiCord services are provided by Cellaviva

Egypt

FamiCord services are provided by Cell Safe Bank

Kosovo

FamiCord services are provided by Biosave

Macedonia

FamiCord services are provided by Biosave

Montenegro

FamiCord services are provided by Biosave

Serbia

FamiCord services are provided by Biosave

Slovenia

FamiCord services are provided by Biosave

Sweden

FamiCord services are provided by Cellaviva

Ukraine

FamiCord services are provided by UBSK

United Kingdom

FamiCord services are provided by Polski Bank Komórek Macierzystych

News

There is no translation available.

The FamiCord Group strengthens its position in Turkey by investing in a stem cell bank belonging to the Acıbadem Healthcare Group

FamiCord Group has concluded an investment agreement regarding the purchase of shares in the Turkish stem cell bank which has operated so far within the structure of the Acıbadem Healthcare Group.

FamiCord group has now 70% of shares in the newly created Famicord - Acibadem company. The company was formed from a separate part of the enterprise with the Acıbadem Healthcare Group, to which the scope of activities including processing, testing and storage of cord blood was transferred. The remaining 30% of shares will be owned by the Acıbadem Healthcare Group. The purchase is  financed from the resources acquired within a private subscription of PBKM shares which took place last year.